[Congressional Record Volume 143, Number 95 (Tuesday, July 8, 1997)]
[House]
[Pages H4839-H4840]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
FDA AND EPA SHOULD POSTPONE ACTION AFFECTING ASTHMA PATIENTS
Mr. STEARNS. Mr. Speaker, I rise today to bring our colleagues'
attention to the FDA's proposed policy that would deny asthma patients
the medicines they need to help them breathe. I and the gentleman from
New Jersey
[[Page H4840]]
[Mr. Smith] expect to propose a resolution urging the FDA and the EPA
to postpone action on this matter.
Mr. Speaker, 30 million people in the United States today rely on
these medications and as each of us know, some better than others,
these people use a product called a metered dose inhaler, which I will
refer to as MDI, to deliver the medications they need into their lungs.
Over the past 25 years, we have developed many new treatments for
people with asthma, chronic pulmonary disease, and other airway
diseases that prevent people from breathing. In fact, there are now 70
different products available in metered dose inhalers. For people who
cannot breathe, these products are lifesavers and allow people to lead
normal lives.
On March 6, 1997, the Food and Drug Administration surprisingly
issued an advance notice of proposed rulemaking that sets in motion a
process to take these medications away from patients. According to the
FDA, this proposed rule was developed in collaboration with the
Environmental Protection Agency because of EPA's desire to eliminate
all uses of chlorofluorocarbons. These are what are called CFC's, which
I will refer to them as.
CFC's are important in this picture because all metered dose
inhalers, except one, use CFC's, a propellant that gets the medicine
from the inhaler canister into the patients' lungs. Until recently,
CFC's were the only propellant approved by the FDA to do so.
I am told the makers of metered dose inhalers believe that
elimination of CFC's is a worthy goal. Therefore, that is why the
United States and 140 other countries signed a treaty to phase out
CFC's use. I believe this treaty did a good job establishing a process
that allows companies that make products that use CFC's to develop
alternatives and get these to the customers.
The treaty went for the big users of CFC's first. In the United
States we no longer use CFC's in hair sprays, air fresheners, new cars
containing air-conditioning systems, and new refrigerators. Some of us
here in the House may question this altogether, but it is done.
The treaty, however, also acknowledged that some uses were more
difficult to phase out. Asthma medicines were one of them. So why is
the FDA now proposing action that would unnecessarily move up the time
line provided in this international treaty? Why, when FDA's mission is
to provide patients with safe and effective medicines, is it seeking to
ban the safe and effective medicines from patients who require them?
Thousands of Americans fear this proposed policy. I am keenly aware
of the fear my constituents have. A woman in Ocala, my hometown of
Florida, said,
I understand there is an FDA proposal to withdraw certain
inhaler medications. As an asthmatic patient with a daughter
and 3 grandchildren who are also asthmatic, I protest your
proposal vehemently. The CFC and the metered dose inhalers
have minimal impact on the environment, and any one of my
family could suffer or die because of your phasing out the
proposal. You will be responsible.
Another man from Ocala, FL, writes,
In September 1993, I was discharged from the hospital under
the care of a hospice. I had been confined for almost a month
with viral pneumonia and was being treated with a wide range
of medications, including 16 liters a minute of oxygen. The
pulmonary specialist who had attended me had given up hope
and estimated that I could live for perhaps 2 weeks. Needless
to say, they were wrong and I survived but my lungs are
severely damaged. I have been using three different MDI
medications ever since my `recovery' and would not survive
without them. Great strides have been made in elimination of
these products in refrigeration systems and in various
aerosol sprays but MDI products must be viewed in a totally
different way. They are essential to the health of many
persons as opposed to the other products which were used for
comfort or convenience. Moreover, reasonable substitutes have
been found for nonmedical products. This is not the case for
MDI's. Potential substitutes must be subjected to the usual
comprehensive scrutiny that the FDA applies to all
medications. I cannot believe that the tiny amount of CFC's
released by MDI's would produce a detectable level of CFC in
the atmosphere between now and the time a medically safe
substitute can be developed. I urge the FDA and the EPA to
postpone action on elimination of CFC's from metered dose
inhalers until such a medically safe substitute is found.
In conclusion, another woman from Ocala states,
My life depends on MDI's and I am never without three of
them, and they all contain different medicines. I'm 69 years
of age and I've used them most of my adult life and I cannot
understand the big rush suddenly to ban the MDI's. It is
frightening to think of the ban since my very life depends
upon it.
Mr. Speaker, these are just a few of the 10,000 letters that the FDA
has received. I hope my colleagues will sponsor my bill. We must halt
the FDA's action, which is harmful to patients.
____________________